mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-05 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.22 |
0.2 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
0.22 |
0.09 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.22 |
7e-05 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-11 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-11 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.02 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-11 |